Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Eye Infections Treatment Market: By Type of Infection By Medication, By Dosage Form, By Distribution Channel, By Geography
Eye Infections Treatment Market size was valued at US$ 7.2 billion in 2022 and is poised to grow at a CAGR of 3.6% from 2023-29. The global market provides a detailed overview and that can be segmented by type of infection, by medication, by Dosage form, and by distribution channel. By type of infection, the Eye Infections Treatment market growth has been segmented into Conjunctivitis, Blepharitis, Keratitis, Vitritis, Dry Eye, Chorioretinitis and Neuroretinitis. The Conjunctivitis segment is likely to be the largest and fastest-growing segment in terms of type of infection. The rise of this segment is mainly due to a rise in the prevalence of such infections. The segment is expected to witness growth in the forecast period due to the growing number of product launches to cure allergic conjunctivitis. It usually happens in people having seasonal allergies. Based on Medication, the Eye Infections Treatment market is segmented into Corticosteroids, Quinolone Antibiotics, Macrolide Antibiotics, Tetracycline Antibiotics, Polyene Antifungals, Aminoglycoside Antibiotics, and Others. Among these, the Tetracycline Antibiotics medication segment is expected to have a significantly growing market during the forecast period 2022-2028. Based on the Dosage form, the Eye Infections Treatment market is segmented into Gels and Cream, Eye drops, Tablets and Capsules. The Eye drops segment is expected to have a significant share in 2021. Based on the distribution channel, the Eye Infections Treatment market is segmented into Ophthalmology Clinics, Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. The hospital pharmacies segment is expected to have a significant share in 2021. The rise of this segment is mainly because of the surge in patient appointments to hospitals for regular eye check-ups and others issues. Besides, the online pharmacies segment is expected to arise as the fastest-growing segment in the eye infection treatment market share
Eye Infections Treatment Market Key Developments:
Study Period
2024-2030Base Year
2023CAGR
3.6%Largest Market
North AmericaFastest Growing Market
Europe
Technological Advancements in Treatment and Diagnosis for Eye Infections is anticipated to propel the market growth over the forecast years. Moreover, the growing incidence of multiple vision conditions worldwide is burgeoning the market growth over the forecast years.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2022 |
US$ 7.2 billion |
Market CAGR |
3.6% |
By Type of Infection |
|
By Medication |
|
By Dosage Form |
|
Download Free Sample Report
Growing advanced drug delivery methods for conjunctivitis
In January 2022, NovaBay Pharmaceuticals launched new eye drops to treat dry eye symptoms.
High severe effects of drugs and expiry of the patent
1. Executive Summary |
2. Global Eye Infections Treatment Market Introduction |
2.1.Global Eye Infections Treatment Market - Taxonomy |
2.2.Global Eye Infections Treatment Market - Definitions |
2.2.1.Type of Infection |
2.2.2.Medication |
2.2.3.Dosage Form |
2.2.4.Region |
3. Global Eye Infections Treatment Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Eye Infections Treatment Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Eye Infections Treatment Market By Type of Infection, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
5.1. Conjunctivitis |
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Blepharitis |
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Keratitis |
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Vitritis |
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Dry eye |
5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
5.6. Chorioretinitis |
5.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.6.3. Market Opportunity Analysis |
5.7. Neuroretinitis |
5.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.7.3. Market Opportunity Analysis |
6. Global Eye Infections Treatment Market By Medication, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
6.1. Corticosteroids |
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Quinolone Antibiotics |
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Macrolide Antibiotics |
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Tetracycline Antibiotics |
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Polyene Antifungals |
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
6.6. Aminoglycoside Antibiotics |
6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.6.3. Market Opportunity Analysis |
6.7. Others |
6.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.7.3. Market Opportunity Analysis |
7. Global Eye Infections Treatment Market By Dosage Form, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
7.1. Gels and Cream |
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Eye drops |
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Tablets and Capsules |
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8. Global Eye Infections Treatment Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9. North America Eye Infections Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
9.1. Type of Infection Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Conjunctivitis |
9.1.2.Blepharitis |
9.1.3.Keratitis |
9.1.4.Vitritis |
9.1.5.Dry eye |
9.1.6.Chorioretinitis |
9.1.7.Neuroretinitis |
9.2. Medication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Corticosteroids |
9.2.2.Quinolone Antibiotics |
9.2.3.Macrolide Antibiotics |
9.2.4.Tetracycline Antibiotics |
9.2.5.Polyene Antifungals |
9.2.6.Aminoglycoside Antibiotics |
9.2.7.Others |
9.3. Dosage Form Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Gels and Cream |
9.3.2.Eye drops |
9.3.3.Tablets and Capsules |
9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10. Europe Eye Infections Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
10.1. Type of Infection Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Conjunctivitis |
10.1.2.Blepharitis |
10.1.3.Keratitis |
10.1.4.Vitritis |
10.1.5.Dry eye |
10.1.6.Chorioretinitis |
10.1.7.Neuroretinitis |
10.2. Medication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Corticosteroids |
10.2.2.Quinolone Antibiotics |
10.2.3.Macrolide Antibiotics |
10.2.4.Tetracycline Antibiotics |
10.2.5.Polyene Antifungals |
10.2.6.Aminoglycoside Antibiotics |
10.2.7.Others |
10.3. Dosage Form Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Gels and Cream |
10.3.2.Eye drops |
10.3.3.Tablets and Capsules |
10.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
10.4.7. |
11. Asia Pacific (APAC) Eye Infections Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
11.1. Type of Infection Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Conjunctivitis |
11.1.2.Blepharitis |
11.1.3.Keratitis |
11.1.4.Vitritis |
11.1.5.Dry eye |
11.1.6.Chorioretinitis |
11.1.7.Neuroretinitis |
11.2. Medication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Corticosteroids |
11.2.2.Quinolone Antibiotics |
11.2.3.Macrolide Antibiotics |
11.2.4.Tetracycline Antibiotics |
11.2.5.Polyene Antifungals |
11.2.6.Aminoglycoside Antibiotics |
11.2.7.Others |
11.3. Dosage Form Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Gels and Cream |
11.3.2.Eye drops |
11.3.3.Tablets and Capsules |
11.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12. Middle East and Africa (MEA) Eye Infections Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
12.1. Type of Infection Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Conjunctivitis |
12.1.2.Blepharitis |
12.1.3.Keratitis |
12.1.4.Vitritis |
12.1.5.Dry eye |
12.1.6.Chorioretinitis |
12.1.7.Neuroretinitis |
12.2. Medication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Corticosteroids |
12.2.2.Quinolone Antibiotics |
12.2.3.Macrolide Antibiotics |
12.2.4.Tetracycline Antibiotics |
12.2.5.Polyene Antifungals |
12.2.6.Aminoglycoside Antibiotics |
12.2.7.Others |
12.3. Dosage Form Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Gels and Cream |
12.3.2.Eye drops |
12.3.3.Tablets and Capsules |
12.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13. Latin America Eye Infections Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
13.1. Type of Infection Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Conjunctivitis |
13.1.2.Blepharitis |
13.1.3.Keratitis |
13.1.4.Vitritis |
13.1.5.Dry eye |
13.1.6.Chorioretinitis |
13.1.7.Neuroretinitis |
13.2. Medication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Corticosteroids |
13.2.2.Quinolone Antibiotics |
13.2.3.Macrolide Antibiotics |
13.2.4.Tetracycline Antibiotics |
13.2.5.Polyene Antifungals |
13.2.6.Aminoglycoside Antibiotics |
13.2.7.Others |
13.3. Dosage Form Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Gels and Cream |
13.3.2.Eye drops |
13.3.3.Tablets and Capsules |
13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Boehringer Ingelheim GmbH (Germany) |
14.2.2.Allergan Inc. (Ireland) |
14.2.3.Sanofi-Aventis (France) |
14.2.4.Novartis AG (Switzerland) |
14.2.5.Bausch & Lomb Inc. (USA) |
14.2.6.CIBA Vision Ophthalmics (USA) |
14.2.7.Pfizer Inc. (USA) |
14.2.8.Merck & Co., Inc. (USA) |
15. Research Methodology |
16. Appendix and Abbreviations |
Key Market Players